Location History:
- Longstock, Nr. Stockbridge, Hampshire, GB (1988)
- Cardiff, GB (2008 - 2013)
- Dundee, GB (2005 - 2015)
- Harlow Essex, GB (2018)
- Harlow, GB (2021)
Company Filing History:
8 out of 56 
4 out of 2,078 
2 out of 1,231 
Years Active: 1988-2021
Title: The Innovative Contributions of Simon Richard Green
Introduction
Simon Richard Green, an accomplished inventor based in Cardiff, GB, has made significant strides in pharmaceutical innovation. With a total of 10 patents to his name, his work particularly focuses on methods for treating proliferative disorders, showcasing his commitment to advancing medical technology and patient care.
Latest Patents
Among his latest inventions is a revolutionary dosage regimen for sapacitabine and seliciclib. This patented method emphasizes the administration of a therapeutically effective amount of these compounds through well-defined treatment cycles. The first treatment cycle involves administering sapacitabine for 3 to 5 consecutive days over two weeks, beginning on the first day of treatment, followed by optional administration of seliciclib the day before. This cycle is then succeeded by a rest period of at least two weeks or until any treatment-related toxicities are resolved. The second treatment cycle follows a similar regimen.
In addition, Green’s patent for the combination of a purine-based CDK inhibitor with a tyrosine kinase inhibitor presents a novel approach to treating proliferative disorders. This invention incorporates a blend of an ErbB inhibitor and CDK inhibitors, yielding numerous possibilities for pharmaceutical product development and treatment methodologies.
Career Highlights
Simon has worked with notable institutions including Cyclacel Limited, where he contributed to innovative cancer therapies, and the International Rectifier Corporation, which showcases his diverse expertise in technology and pharmaceuticals. His inventive prowess has allowed him to file a variety of patents that address pressing medical challenges.
Collaborations
Throughout his career, Green has collaborated with distinguished colleagues such as Ian Fleming and Ruth Mackay. These partnerships have facilitated the sharing of knowledge and the development of groundbreaking ideas, further propelling advancements in therapeutic methodologies.
Conclusion
Simon Richard Green's contributions to the field of pharmaceutical sciences exemplify the intersection of innovation and healthcare. With a prominent portfolio of ten patents and collaborative efforts with industry experts, Green continues to inspire future inventions and treatments in the medical landscape. His work not only reflects the essence of invention but also offers hope for patients suffering from proliferative disorders.